Pulmonary alveolar proteinosis: from classification to therapy
Pulmonary alveolar proteinosis (PAP) is a rare respiratory syndrome characterised by the accumulation of surfactant lipoproteins within the alveoli. According to various pathogenetic mechanisms and aetiologies, PAP is classified as primary, secondary or congenital. Primary PAP is led by a granulocyt...
Main Authors: | Elena Salvaterra, Ilaria Campo |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2020-06-01
|
Series: | Breathe |
Online Access: | http://breathe.ersjournals.com/content/16/2/200018.full |
Similar Items
-
Therapy options in pulmonary alveolar proteinosis
by: Maurizio Luisetti, et al.
Published: (2010-08-01) -
Proteinosis alveolar pulmonar Pulmonary alveolar proteinosis
by: Concepción Sánchez Infante, et al.
Published: (2011-12-01) -
Pulmonary alveolar proteinosis: diagnostic and therapeutic challenges
by: Campo Ilaria, et al.
Published: (2012-06-01) -
Pulmonary alveolar proteinosis
by: B. Crestani, et al.
Published: (2011-06-01) -
Pulmonary alveolar proteinosis
by: Hadice Selimoğlu Şen, et al.
Published: (2011-06-01)